UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

Neurology, 2009-10, Vol.73 (15), p.1200-1206

2009

Volltextzugriff (PDF)

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

European radiology, 2016-06, Vol.26 (6), p.1606-1612

2016

Volltextzugriff (PDF)

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

British journal of cancer, 2009-10, Vol.101 (7), p.1137-1144

2009

Volltextzugriff (PDF)

ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression

Oncogene, 2006-08, Vol.25 (39), p.5462-5466

2006

Volltextzugriff (PDF)

SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT

The Journal of urology, 2000-03, Vol.163 (3), p.730-736

2000

Volltextzugriff (PDF)

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature

Cancer research (Chicago, Ill.), 1999-07, Vol.59 (13), p.3192-3198

1999

Volltextzugriff (PDF)

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer

International journal of radiation oncology, biology, physics, 1998-06, Vol.41 (3), p.491-500

1998

Volltextzugriff (PDF)

The Heidelberg classification of renal cell tumours

The Journal of pathology, 1997-10, Vol.183 (2), p.131-133

1997

Volltextzugriff (PDF)

Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers

Clinical cancer research, 1998-02, Vol.4 (2), p.295-302

1998

Volltextzugriff (PDF)

Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney

The American journal of surgical pathology, 2000-08, Vol.24 (8), p.1087-1096

2000

Volltextzugriff (PDF)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

British journal of cancer, 2010-02, Vol.102 (4), p.678-684

2010

Volltextzugriff (PDF)

Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy

Urology (Ridgewood, N.J.), 1997-03, Vol.49 (3), p.16-22

Reuter, Victor E.

1997

Volltextzugriff (PDF)

TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS

The Journal of urology, 1998, Vol.159 (1), p.133-138

1998

Volltextzugriff (PDF)

Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

JNCI : Journal of the National Cancer Institute, 1993-01, Vol.85 (1), p.53-59

1993

Volltextzugriff (PDF)

Deletion of the p16 and p15 Genes in Human Bladder Tumors

JNCI : Journal of the National Cancer Institute, 1995-10, Vol.87 (20), p.1524-1529

1995

Volltextzugriff (PDF)

Contemporary approach to the classification of renal epithelial tumors

Seminars in oncology, 2000-04, Vol.27 (2), p.124-137

2000

Volltextzugriff (PDF)

Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer

JNCI : Journal of the National Cancer Institute, 1992-08, Vol.84 (16), p.1251-1256

1992

Volltextzugriff (PDF)

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

Journal of clinical oncology, 1995-06, Vol.13 (6), p.1384-1390

1995

Volltextzugriff (PDF)

Preferential Association of Human Papillomavirus With High-Grade Histologic Variants of Penile-Invasive Squamous Cell Carcinoma

JNCI : Journal of the National Cancer Institute, 1995-11, Vol.87 (22), p.1705-1709

1995

Volltextzugriff (PDF)

Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome

Histopathology, 2007-10, Vol.51 (4), p.452-457

2007

Volltextzugriff (PDF)

Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors

Cancer research (Chicago, Ill.), 1997-04, Vol.57 (7), p.1217-1221

1997

Volltextzugriff (PDF)

Renal oncocytosis: a morphologic study of fourteen cases

The American journal of surgical pathology, 1999-09, Vol.23 (9), p.1094

1999

Volltextzugriff (PDF)

Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation

Oncogene, 1998-05, Vol.16 (18), p.2345-2349

1998

Volltextzugriff (PDF)

Second primary malignancies associated with renal cell carcinoma: influence of histologic type

Urology (Ridgewood, N.J.), 2000-09, Vol.56 (3), p.399-403

2000

Volltextzugriff (PDF)

1 – 25 von 583

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(527)
Mit Volltextzugriff
(427)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression

SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer

The Heidelberg classification of renal cell tumours

Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers

Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy

TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS

Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

Deletion of the p16 and p15 Genes in Human Bladder Tumors

Contemporary approach to the classification of renal epithelial tumors

Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

Preferential Association of Human Papillomavirus With High-Grade Histologic Variants of Penile-Invasive Squamous Cell Carcinoma

Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome

The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers

Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors

Renal oncocytosis: a morphologic study of fourteen cases

Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation

Second primary malignancies associated with renal cell carcinoma: influence of histologic type

Suchergebnisse filtern